Cognito Therapeutics, Inc.
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimers disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimers disease and expects to start pivotal studies in 2022. The companys technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
Cognito Therapeutics, Inc.
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimers disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimers disease and expects to start pivotal studies in 2022. The companys technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
cognitotx.com
Cambridge, MA 02138, US
Details
Year founded
2016
Revenue
1M-5M
Employees
11-50
Number of locations
1
NAICS
3391
SIC
3841
Products & Services
Outlines the company's specialized services and operational strengths.
- Disease-modifying treatments
- Non-invasive neuromodulation
- Wearable device
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Non-invasive therapeutic intervention equipment for evoking gamma wave activity through visual and auditory stimulation
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that cognito therapeutics is ramping up production.
Target industries
Employees working in Cognito Therapeutics, Inc.
News
Exploring Flashing Lights and Sounds to Slow Alzheimer’s Brain Shrinkage
Exploring Flashing Lights and Sounds to Slow Alzheimer’s Brain Shrinkage
Cognito Therapeutics' experimental headset, Spectris, which stimulates the brain, is heading to Phase 3 trials.
Locations (1)
Cognito Therapeutics, Inc.
Cambridge, MA 02138, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Cognito Therapeutics, Inc. offer?
Cognito Therapeutics, Inc. offers a range of services and capabilities, including Disease-modifying treatments.
What kind of equipment does Cognito Therapeutics, Inc. use?
Cognito Therapeutics, Inc. uses a variety of equipment, including Non-invasive therapeutic intervention equipment for evoking gamma wave activity through visual and auditory stimulation.
What are the target industries of Cognito Therapeutics, Inc.?
Cognito Therapeutics, Inc. serves several industries, including the medical industry.
How many locations does Cognito Therapeutics, Inc. operate?
Cognito Therapeutics, Inc. operates from a single location at cambridge, massachusetts 02138, united states.
Where are the headquarters of Cognito Therapeutics, Inc.?
The headquarters of Cognito Therapeutics, Inc. are located in cambridge, massachusetts 02138, united states.
What is the NAICS code for Cognito Therapeutics, Inc.?
The NAICS code for Cognito Therapeutics, Inc. is 3391.
How many employees does Cognito Therapeutics, Inc. have?
Cognito Therapeutics, Inc. has 47 employees.
What is the official website of Cognito Therapeutics, Inc.?
The official website of Cognito Therapeutics, Inc. is https://www.cognitotx.com/.
When was Cognito Therapeutics, Inc. founded?
Cognito Therapeutics, Inc. was founded in 2016.